South Korea Medical Tubing Market Size, Share, Industry Overview, Trends and Forecast 2033

IMARC Group has recently released a new research study titled “South Korea Medical Tubing Market Size, Share, Trends and Forecast by Product, Structure, Application, End User, and Region, 2025-2033”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.

South Korea Medical Tubing Market Overview

The South Korea Medical Tubing Market size was valued at USD 275.50 Million in 2024 and is forecast to grow to USD 553.71 Million by 2033. The market is expected to grow at a compound annual growth rate (CAGR) of 7.23% during the forecast period 2025-2033. Growth is driven by rising demand for minimally invasive devices, increased healthcare infrastructure, and advances in catheter-based and diagnostic technologies. Manufacturers are investing in high-performance materials like silicone, TPU, and PTFE to meet strict medical standards.

Study Assumption Years

  • Base Year: 2024
  • Historical Year/Period: 2019-2024
  • Forecast Year/Period: 2025-2033

South Korea Medical Tubing Market Key Takeaways

  • Current Market Size: USD 275.50 Million (2024)
  • CAGR: 7.23% (2025-2033)
  • Forecast Period: 2025-2033
  • The market’s growth is supported by increased use of minimally invasive medical devices and expanding healthcare infrastructure.
  • Local and international manufacturers focus on using advanced materials such as silicone, TPU, and PTFE for medical tubing.
  • Regulatory compliance with KFDA, ISO, and FDA standards is a critical factor driving innovation and quality improvements.
  • Integrated device solutions combining tubing with catheters and diagnostic devices are enhancing clinical performance.
  • The market includes segments based on product, structure, application, end user, and region, each with detailed analyses.

Sample Request Link: https://www.imarcgroup.com/south-korea-medical-tubing-market/requestsample

Market Growth Factors

The South Korea medical tubing market is expanding steadily with a strong CAGR of 7.23% forecasted from 2025 to 2033. This growth is primarily fueled by increasing demand for minimally invasive devices, which require specialized tubing components for catheters, infusion sets, and diagnostic equipment. The local healthcare infrastructure improvements and rising adoption of advanced diagnostic technologies further strengthen market demand. Manufacturers are actively investing in advanced materials such as silicone, thermoplastic polyurethane (TPU), and polytetrafluoroethylene (PTFE), which comply with rigorous medical standards, ensuring durability, sterility, and safety.

Integrated device solutions have become a crucial trend within the South Korea medical tubing market. Tubing is now seen not as an isolated component but as part of comprehensive medical systems. This has led to collaborations between tubing manufacturers and medical device producers to co-develop sterilizable and regulation-compliant systems, which improve device compatibility and reduce treatment durations. For example, in May 2025, researchers at Asan Medical Center developed a photodynamic therapy catheter featuring a laser delivery channel, representing innovation driven by clinical needs and market demand.

Regulatory compliance is another vital growth factor. The Medical Device and IVD regulatory framework in South Korea, overseen by MFDS and KFDA, has seen enhancements such as updated K-GMP regulations (MFDS Notice No. 2025-22) that establish "excellent quality control" standards, desktop audits, and updated oversight for Class 3 devices. These regulations encourage manufacturers to adopt state-of-the-art sterilization, cleanroom production environments, and quality management systems. Such compliance not only ensures product safety and efficacy but also opens avenues for export and global market access, positioning South Korea as a trusted player in the global medical tubing arena.

Market Segmentation

Product:

  • Silicone: High-performance material used extensively in medical tubing for flexibility and biocompatibility.
  • Polyolefins: Thermoplastic resins providing versatility in tubing applications.
  • Polyvinyl Chloride: Commonly used for cost-effective and flexible tubing solutions.
  • Polycarbonates: Durable plastics employed where structural integrity is critical.
  • Fluoropolymers: Provide excellent chemical resistance and high performance in medical applications.
  • Others: Include other specialty materials catering to niche tubing requirements.

Structure:

  • Single-Lumen: Tubing with a single channel for fluid transfer.
  • Co-Extruded: Tubing manufactured with multiple layers to combine material benefits.
  • Multi-Lumen: Tubing containing multiple channels used for complex medical functions.
  • Tapered or Bump Tubing: Tubing designed with varied diameter sections for specific procedural needs.
  • Braided Tubing: Reinforced tubing with braided structure for strength and flexibility.

Application:

  • Bulk Disposable Tubing: Used in general disposable medical applications.
  • Drug Delivery Systems: Specialized tubing integrated within devices delivering pharmaceuticals.
  • Catheters: Critical application sector demanding high precision and safety.
  • Biopharmaceutical Laboratory Equipment: Tubing for pharmaceutical research and development equipment.
  • Others: Other uses in various medical applications outside main categories.

End User:

  • Hospitals and Clinics: Major consumers of medical tubing products for numerous treatments.
  • Ambulatory Surgical Centers: Facilities employing tubing for surgical and outpatient applications.
  • Medical Labs: Utilize tubing in diagnostic and research operations.
  • Others: Other healthcare settings using medical tubing components.

Ask For an Analyst-  https://www.imarcgroup.com/request?type=report&id=39456&flag=C

Regional Insights

The dominant region in the South Korea medical tubing market is the Seoul Capital Area. Other major regions include Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region), and others. While exact regional market shares or CAGR per region are not explicitly provided in the source, these regions are considered key markets for medical tubing demand given their medical infrastructure density.

Recent Developments & News

In December 2024, MicroPort CardioFlow’s VitaFlow Liberty Transcatheter Aortic Valve and Retrievable Delivery System secured marketing approval from South Korea's Ministry of Food and Drug Safety. This innovative TAVI device features an electric retrieval mechanism enhancing surgical accuracy and benefiting over 10,000 patients across 700 hospitals globally. In the same month, WSI announced plans to supply central venous and peripherally inserted central catheters to over 50 South Korean hospitals, including Seoul National University Hospital, projecting sales exceeding 3 billion won in the following year.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302